P2Y12 Inhibitors: Pharmacologic Mechanism and Clinical Relevance

Publisher： Bentham Science Publishers

E-ISSN： 1875-6182|11|2|101-105

ISSN： 1871-5257

Source： Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol.11, Iss.2, 2013-06, pp. : 101-105

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

P2Y12 Receptor Antagonists in Acute Coronary Syndrome: Clinical Implications of Pharmacologic and Pharmacogenetic Differences

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 6, Iss. 3, 2011-09 ,pp. : 207-214

Bentham Science Publishers

Access to resources Recommend Favorite

Newer P2Y12 Inhibitors: How Does the Interventional Cardiologist Choose?

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 9, 2016-09 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evidence that the purinergic receptor P2Y12 potentiates platelet shape change by a Rho kinase-dependent mechanism

By Hardy Adam R.   Hill Darryl J.   Poole Alastair W.  

Platelets, Vol. 16, Iss. 7, 2005-11 ,pp. : 415-429

Informa Healthcare

Access to resources Recommend Favorite

A clinician's perspective of emerging P2Y12-directed pharmacotherapies, ex vivo measurement tools, and clinical outcomes

By Berger Jeffrey   Becker Richard  

Platelets, Vol. 20, Iss. 5, 2009-08 ,pp. : 302-315

Informa Healthcare

Access to resources Recommend Favorite

P2Y12 receptor in platelet activation

By Kim Soochong   Kunapuli Satya P.  

Platelets, Vol. 22, Iss. 1, 2011-02 ,pp. : 54-58

Informa Healthcare

Access to resources Recommend Favorite